Misinformation about medication during the COVID- 19 pandemic: A perspective of medical staff.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 28 03 2022
accepted: 12 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 1 11 2022
Statut: epublish

Résumé

Healthcare professionals had to face numerous challenges during the pandemic, their professional activity being influenced not only by the virus, but also by the spread of medical misinformation. In this regard, we aimed to analyze, from the perspective of medical staff, the way medical and non-medical information about the virus was communicated during the pandemic to encourage the development of future research or interventions in order to raise awareness about the way misinformation affected medical staff. The study was conducted on Romanian healthcare professionals. They were asked to answer to a questionnaire and the sample of the research includes 536 respondents. The findings revealed that most respondents stated that information about alternative treatments against the virus affected the credibility of health professionals, and that younger professionals believed to a greater extent that trust in doctors was affected. The research also showed that respondents were well informed about the drugs used in clinical trials in order to treat the virus. Healthcare professionals declared that the spread of misinformation regarding alternative treatments, affected their credibility and the relationship with their patients. Healthcare professionals had knowledge about the drugs used in clinical trials, and they acknowledged the role of social media in spreading medical misinformation. However, younger professionals also believed that social media could be used to share official information about the virus.

Sections du résumé

BACKGROUND
Healthcare professionals had to face numerous challenges during the pandemic, their professional activity being influenced not only by the virus, but also by the spread of medical misinformation. In this regard, we aimed to analyze, from the perspective of medical staff, the way medical and non-medical information about the virus was communicated during the pandemic to encourage the development of future research or interventions in order to raise awareness about the way misinformation affected medical staff.
METHODS AND FINDINGS
The study was conducted on Romanian healthcare professionals. They were asked to answer to a questionnaire and the sample of the research includes 536 respondents. The findings revealed that most respondents stated that information about alternative treatments against the virus affected the credibility of health professionals, and that younger professionals believed to a greater extent that trust in doctors was affected. The research also showed that respondents were well informed about the drugs used in clinical trials in order to treat the virus.
CONCLUSIONS
Healthcare professionals declared that the spread of misinformation regarding alternative treatments, affected their credibility and the relationship with their patients. Healthcare professionals had knowledge about the drugs used in clinical trials, and they acknowledged the role of social media in spreading medical misinformation. However, younger professionals also believed that social media could be used to share official information about the virus.

Identifiants

pubmed: 36301877
doi: 10.1371/journal.pone.0276693
pii: PONE-D-22-09134
pmc: PMC9612566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0276693

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cad Saude Publica. 2020;36(7):e00101920
pubmed: 32725084
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Eur J Emerg Med. 2020 Oct;27(5):327-328
pubmed: 32332201
Pediatr Res. 2022 Feb;91(3):482-485
pubmed: 34853429
PLoS One. 2021 Jun 23;16(6):e0253497
pubmed: 34161383
J Chin Med Assoc. 2020 Jun;83(6):534-536
pubmed: 32243270
Int J Environ Res Public Health. 2020 Apr 03;17(7):
pubmed: 32260048
Ir Med J. 2020 May 07;113(5):85
pubmed: 32603577
PLoS Med. 2020 Sep 3;17(9):e1003252
pubmed: 32881895
Science. 2018 Mar 9;359(6380):1094-1096
pubmed: 29590025
J Med Internet Res. 2020 Aug 19;22(8):e19996
pubmed: 32750004
J Exp Psychol Appl. 2021 Dec;27(4):773-784
pubmed: 34110860
Bull World Health Organ. 2009 Aug;87(8):566
pubmed: 19704998
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Drug Saf. 2020 Aug;43(8):699-709
pubmed: 32572842
Z Gesundh Wiss. 2021 Oct 09;:1-10
pubmed: 34660175
Health Commun. 2018 Sep;33(9):1131-1140
pubmed: 28622038
Cureus. 2020 Nov 5;12(11):e11346
pubmed: 33304681
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Prog Disaster Sci. 2020 Dec;8:100119
pubmed: 34173443
Psychol Sci. 2020 Jul;31(7):770-780
pubmed: 32603243
PLoS One. 2020 Oct 21;15(10):e0240776
pubmed: 33085719
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
PLoS One. 2020 Oct 14;15(10):e0240005
pubmed: 33052967
Infect Dis Ther. 2021 Mar;10(1):253-268
pubmed: 33135113
JAMA. 2020 Apr 7;323(13):1243-1244
pubmed: 32077901
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
JAMA. 2018 Dec 18;320(23):2417-2418
pubmed: 30428002
Rom J Morphol Embryol. 2018;59(2):631-636
pubmed: 30173275
Vaccines (Basel). 2021 Aug 23;9(8):
pubmed: 34452058
Science. 2020 Mar 27;367(6485):1412-1413
pubmed: 32217705
Drug Discov Ther. 2020 May 6;14(2):67-72
pubmed: 32336723
Digit Health. 2021 Jun 29;7:20552076211028034
pubmed: 34277029
BMC Public Health. 2021 Apr 8;21(1):684
pubmed: 33832446
J Paediatr Child Health. 2020 Oct;56(10):1645-1646
pubmed: 32862506
Healthcare (Basel). 2021 Feb 02;9(2):
pubmed: 33540762
Int J Environ Res Public Health. 2020 Aug 12;17(16):
pubmed: 32806772
Lancet. 2020 Feb 29;395(10225):676
pubmed: 32113495
JAMA. 2020 Oct 6;324(13):1282-1283
pubmed: 32870235
Int J Antimicrob Agents. 2020 Apr;55(4):105945
pubmed: 32194152
Rev Panam Salud Publica. 2020 Mar 20;44:e40
pubmed: 32256547
Front Psychol. 2021 Jul 09;12:643758
pubmed: 34305713
BMC Health Serv Res. 2021 Aug 24;21(1):865
pubmed: 34429101
JAMA. 2020 May 12;323(18):1824-1836
pubmed: 32282022
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Clin Microbiol Infect. 2020 Sep;26(9):1259.e5-1259.e7
pubmed: 32535147
Rom J Morphol Embryol. 2014;55(2 Suppl):719-22
pubmed: 25178352
Am J Ther. 2021 Jun 22;28(4):e478-e487
pubmed: 34228653
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Inquiry. 2021 Jan-Dec;58:469580211035742
pubmed: 34399597
BMC Med. 2020 Mar 18;18(1):89
pubmed: 32188445
J Prev Med Public Health. 2020 May;53(3):171-174
pubmed: 32498140
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204

Auteurs

Claudiu Coman (C)

Department of Social Sciences and Communication, Faculty of Sociology and Communication, Transilvania University of Brasov, Brasov, Romania.

Maria Cristina Bularca (MC)

Department of Social Sciences and Communication, Faculty of Sociology and Communication, Transilvania University of Brasov, Brasov, Romania.

Angela Repanovici (A)

Department of Product Design, Mechatronics and Environment, Faculty of Product Design and Environment, Transilvania University of Brasov, Brasov, Romania.

Liliana Rogozea (L)

Basic, Preventive and Clinical Sciences Department, Transilvania University of Brasov, Brasov, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH